Announcements Trials

Browse Landscape Eligibility

Clinical Trials

1 trials

Recent Start date Enrollment

Has results × Obesity × penclomedine × Clear all

Phase

Status

Sponsor Class

Study Type

Interventional 1

Sponsor

Cancer Type

Conditions

Polycystic Ovary Syndrome 1 Obesity 1 Fatty Liver 1

Interventions

Metformin 5 Exenatide 4 Vitamin D 2 penclomedine 1 licogliflozin 1 exemestane 1 dapagliflozin 1 bupropion hydrochloride, naltrexone hydrochoride drug combination 1 Therapeutics 1 Testosterone 1 Taxes 1 Tamoxifen 1 Sugars 1 Sugammadex 1 Sodium-Glucose Transporter 2 Inhibitors 1 Resistance Training 1 Radiotherapy, Intensity-Modulated 1 Radiotherapy, Conformal 1 Qsymia 1 Progesterone 1 Paclitaxel 1 Observation 1 Naltrexone 1 Methods 1 Letrozole 1 Glucocorticoids 1 Glucagon-Like Peptide 1 1 Excitatory Amino Acids 1 Estrogens 1 Doxorubicin 1

Date Range

30 days 90 days 1 year All

Options

Has results Has announcements

NCT02157974 2024-06-04

APPLE

University of Colorado, Denver

Phase 2/3 Completed

92 enrolled 17 charts

Fatty Liver, Obesity, Polycystic Ovary Syndrome

Data powered by HemOnc (CC BY 4.0) Colophon ⚡